NSEAppointment8 Jul 2026 · 8 Jul 2026, 02:47 pm

Appointment

Fortis Healthcare Limited · FORTIS

✦ AI SummaryMgmt Change

Fortis Healthcare Limited has appointed Dr. Ashutosh Raghuvanshi as Managing Director & CEO for a further period of two years, effective from March 19, 2027, subject to shareholder approval.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fortis Healthcare Limited has informed the Exchange regarding Appointment of Dr. Ashutosh Raghuvanshi as Managing Director & CEO of the company w.e.f. March 19, 2027.

Attachments (1)

📄

FORTIS_08072026144456_OUTCOMEOFBM.pdf

pdf

Download →
View document text
Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com FHL/SEC/2026-27 July 08, 2026 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code:532843 Sub: Outcome of the Board Meeting under Regulation 30 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 Dear Madam/Sir, Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (“SEBI Listing Regulations”), read with SEBI Master Circular O/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we wish to inform you that subject to the approval of shareholders, the Board of Directors of the Company at its meeting held today i.e. July 8, 2026 have, inter-alia, considered and approved the following matters: - Recommend the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer) of the company for a further period of Two years effective from March 19, 2027, not liable to retire by rotation; The detailed disclosure as required under SEBI Master Circular No. O/49/14/14(7)2025-CFD-POD2/I/3762/2026 dates January 30, 2026 is enclosed as Annexure-A. Further, Dr. Ashutosh Raghuvanshi, is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority The Board Meeting commenced at 01:00 PM IST and concluded at 02:30 PM IST. This is for your information and record. Thanking You, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer M. No. A14783 Encl :a/a FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com Annexure A Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master circular dated January 30, 2026 Sr. No Particulars Description 1. Reason for change viz. appointment, re- The current term of Dr. Ashutosh Raghuvanshi as appointment, resignation, removal, death or Managing Director (designated as Managing otherwise; Director and Chief Executive Officer) is expiring on March 18, 2027. Considering the expertise and his role in steering the growth of the Company, the Board of Directors in their meeting held today recommended his re-appointment for a further period of Two years effective from March 19, 2027. 2. Date of appointment/re-appointment/cessation Subject to approval of the shareholders, the (as applicable) & term of appointment/re- reappointment will be for Two years effective from appointment March 19, 2027. 3. Brief profile (in case of appointment). Dr. Ashutosh Raghuvanshi, aged about 64 years, holds an MBBS and an M.S. in General Surgery from Mahatma Gandhi Institute of Medical Sciences, Wardha, and an M.Ch. in Cardiac Surgery from Bombay Hospital Institute of Medical Sciences, India. He currently serves as the Managing Director & Chief Executive Officer of the Company. Dr. Raghuvanshi brings over 38 years of experience in the healthcare sector and has received numerous national and international awards in recognition of his contributions to the industry. Prior to joining Fortis Healthcare, Dr. Raghuvanshi spent over 18 years with Narayana Health, a leading healthcare chain operating over 28 hospitals, where he held several leadership positions including as its Vice Chairman, Managing Director and Group Chief Executive Officer (MD & CEO). Dr. Ashutosh Raghuvanshi's journey reflects his multifaceted role as a distinguished cardiac surgeon, seasoned healthcare administrator, and visionary leader. His journey from a successful clinician to a dynamic management professional has significantly contributed to the success and growth of major healthcare institutions in India. He is closely engaged with industry bodies including CII, FICCI, and NATHEALTH, having served as President of NATHEALTH from 2023 to 2024. FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com 4. Disclosure of relationships between directors Dr. Raghuvanshi is not related to any of the other (in case of appointment of a director). Directors of the Company. FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933